Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Vermont for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Vermont only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Vermont (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Vermont Cvs Pharmacy, LLC (NPI 1225132038)

Field	Value
Entity Type	Organization
Organization	Vermont Cvs Pharmacy, LLC
Address	31 N Main St # 33
City	Rutland
State	VT
ZIP	05701
Taxonomy	Pharmacy
NPI Enumerated	September 12, 2006

Payer Source	Total Paid
Medicare	$179.9K
Medicaid	$0

Key Findings

VERMONT CVS PHARMACY, LLC is a pharmacy-focused outpatient immunization and testing site based on its Medicare code mix: high-volume vaccine administration codes (91322, 90677, 90694, multiple influenza administration codes) and a large count of nonprescription COVID test claims (K1034) indicate operations centered on vaccine delivery and point-of-care COVID testing rather than durable medical equipment or clinical procedures. The presence of numerous influenza and pneumococcal vaccine codes across Medicare claims aligns with typical retail pharmacy immunization services.

This provider’s Medicare revenue totals $179.9K with no Medicaid billing on file, making its public payer footprint effectively single-payer (Medicare-only) in the available datasets. Analysts should treat this entity as dependent on Medicare flows for the observed revenue activity and not assume any Medicaid volume or reimbursement relationships exist in the record.

Revenue is concentrated: the precomputed top-three Medicare codes account for 64.1% of the provider’s total Medicare revenue, indicating most Medicare receipts derive from a small set of services. Specifically, 91322 ($50.2K, 28.0%), 90677 ($32.6K, 18.2%), and K1034 ($32.2K, 17.9%) dominate the revenue profile, so changes in vaccine demand or COVID-test reimbursement would likely have outsized effects on overall revenue.

On code-level competitive standing, the provider shows modest-to-strong national placement for its highest-volume codes but not dominance. For 90677 it ranks #529 of 52451 providers (99th percentile), and for 91322 and K1034 it ranks in the 96th percentile nationally, which signals unusually high relative activity for pneumococcal vaccination and elevated but not singular activity for the COVID vaccine and over-the-counter COVID test provisioning. These percentiles suggest the pharmacy is a significant local immunizer for certain vaccines compared with national peers.

Operational scale is modest in absolute terms: total Medicare revenue of $179.9K and examples like 351 claims for 91322 and 3.2K claims for K1034 show this location handles substantial transactional volume for point-of-care services (many low-dollar test claims plus fewer higher-paid vaccine administrations) rather than large, high-dollar episodic procedures. The mix of hundreds of vaccine administrations and thousands of low-dollar test claims fits a retail pharmacy model that relies on high transaction counts.

Tenure is long-standing: the NPI was enumerated on 2006-09-12 (~20 years ago), which indicates the entity has an established billing presence and multi-year Medicare enrollment. That longevity supports interpretation of the observed patterns as mature operational behavior rather than a brief trial or recent entrant.

Payer-mix risk and strategic implications: because no Medicaid billing is present, the provider’s ability to capture growth or offset revenue fluctuation is constrained to Medicare and commercial/self-pay channels (the latter not visible here). Any payer or policy changes affecting Medicare vaccine or COVID-test reimbursement would be concentrated risk for this site given the 64.1% revenue concentration in three codes. Analysts should consider how pharmacy-level retail programs or public health vaccine campaigns could materially influence future Medicare receipts.

Code-level utilization nuances: multiple influenza administration codes (90480, G0008, 90694, 90662, 90686) together represent a meaningful share of revenue and claims activity, underscoring seasonality in revenue and workload tied to annual flu campaigns. The presence of both vaccine-product codes and separate vaccine-administration codes indicates standard billing of product plus administration rather than bundled atypical reporting.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

10 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
91322	This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL.	350	$140	$50.2K
90677	This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the…	120	$280	$32.6K
K1034	Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count	3,220	$10	$32.2K
90694	This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL…	300	$80	$23K
90480	The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19.	350	$40	$14.1K
G0008	Administration of influenza virus vaccine	440	$30	$13.3K
90662	This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection…	120	$70	$8.9K
0134A	N/A	90	$40	$3.6K
G0009	Administration of pneumococcal vaccine	110	$10	$1.3K
90686	This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL…	10	$20	$240

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 10 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Vermont Distribution

Vermont Cvs Pharmacy, LLC — 5 of 10 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Vermont

Full comparison — all codes billed, vs. state median

10 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
91322	8	60	180	$140	$34.2K
90694	6	60	90	$80	$10.7K
K1034	2	60	750	$10	$9.4K
90480	15	110	130	$40	$7.8K
90677	1	80	20	$270	$6.8K
90662	27	140	50	$70	$6.1K
G0008	7	170	70	$20	$3.5K
0134A	2	40	20	$40	$1.3K
G0009	1	70	20	$30	$610
90686	40	40	20	$20	$590

Nearby Providers

Other providers in the same ZIP code as Vermont Cvs Pharmacy, LLC, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Rutland Mental Health Services	VT	Developmental Disabilities Clinic/Center	$0	$122.1M
Community Health Centers Of The Rutland Region Inc	VT	Federally Qualified Health Center (FQHC)	$0	$20.6M
Rutland Mental Health Services, Inc.	VT	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$17.7M
Rutland Hospital, Inc.	VT	Psychiatric Hospital Unit	$396.2K	$13.3M
Community Health Centers Of The Rutland Region, Inc.	VT	Pediatrics Physician	$0	$13.6M
Regional Ambulance Service, Inc	VT	Land Ambulance	$1.4M	$5.3M
Vna & Hospice Of The Southwest Region, Inc	VT	Home Health Agency	$0	$4.8M
Bradford Psychiatric Associates. LLC	VT	Addiction Medicine (Internal Medicine) Physician	$0	$4.7M
Community Health Centers Of The Rutland Region, Inc.	VT	Dentist	$0	$4.4M
Community Health Centers Of The Rutland Region, Inc.	VT	Federally Qualified Health Center (FQHC)	$0	$4.3M

Vermont Cvs Pharmacy, LLC — Billing Profile & Reimbursement Data

Sign up for Vermont Cvs Pharmacy, LLC — Billing Profile & Reimbursement Data policy alerts

Vermont Cvs Pharmacy, LLC — Billing Profile & Reimbursement Data

Sign up for Vermont Cvs Pharmacy, LLC — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References